|
1
|
Hagmeyer L, Theegarten D, Wohlschläger J,
Treml M, Matthes S, Priegnitz C and Randerath WJ: The role of
transbronchial cryobiopsy and surgical lung biopsy in the
diagnostic algorithm of interstitial lung disease. Clin Respir J.
10:589–595. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Anthimopoulos M, Christodoulidis S, Ebner
L, Christe A and Mougiakakou S: Lung pattern classification for
interstitial lung diseases using a deep convolutional neural
network. IEEE Trans Med Imaging. 35:1207–1216. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Douglas WW, Tazelaar HD, Hartman TE,
Hartman RP, Decker PA, Schroeder DR and Ryu JH:
Polymyositis-dermatomyositis-associated interstitial lung disease.
Am J Respir Crit Care Med. 164:1182–1185. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salisbury ML, Xia M, Murray S, Bartholmai
BJ, Kazerooni EA, Meldrum CA, Martinez FJ and Flaherty KR:
Predictors of idiopathic pulmonary fibrosis in absence of
radiologic honeycombing: A cross sectional analysis in ILD patients
undergoing lung tissue sampling. Respir Med. 118:88–95. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Johannson KA, Marcoux VS, Ronksley PE and
Ryerson CJ: Diagnostic yield and complications of transbronchial
lung cryobiopsy for interstitial lung disease. A systematic review
and metaanalysis. Ann Am Thorac Soc. 13:1828–1838. 2016.PubMed/NCBI
|
|
6
|
Solomon JJ, Chung JH, Cosgrove GP,
Demoruelle MK, Fernandez-Perez ER, Fischer A, Frankel SK, Hobbs SB,
Huie TJ, Ketzer J, et al: Predictors of mortality in rheumatoid
arthritis-associated interstitial lung disease. Eur Respir J.
47:588–596. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mathai SC and Danoff SK: Management of
interstitial lung disease associated with connective tissue
disease. BMJ. 352:h68192016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wallace B, Vummidi D and Khanna D:
Management of connective tissue diseases associated interstitial
lung disease: A review of the published literature. Curr Opin
Rheumatol. 28:236–245. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park SI, Felipe CR, Pinheiro-Machado PG,
Garcia R, Fernandes FB, Casarini DE, Tedesco-Silva H Jr and
Medina-Pestana JO: Tacro-limus pharmacokinetic drug interactions:
Effect of prednisone, mycophenolic acid or sirolimus. Fundam Clin
Pharmacol. 23:137–145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eichhorst B, Fink AM, Bahlo J, Busch R,
Kovacs G, Maurer C, Lange E, Köppler H, Kiehl M, Sökler M, et al
international group of investigators; German CLL Study Group
(GCLLSG), : First-line chemoimmunotherapy with bendamustine and
rituximab versus fludarabine, cyclophosphamide, and rituximab in
patients with advanced chronic lymphocytic leukaemia (CLL10): An
international, open-label, randomised, phase 3, non-inferiority
trial. Lancet Oncol. 17:928–942. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reece DE, Trieu Y, Masih-Khan E, Atenafu
EG, Chen C, Prica A, Tiedemann R, Trudel S and Kukreti V:
Cyclophosphamide and bortezomib with prednisone or dexamethasone
for the treatment of relapsed and refractory multiple myeloma. Clin
Lymphoma Myeloma Leuk. 16:387–394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He QQ, He X, Wang YP, Zou Y, Xia QJ, Xiong
LL, Luo CZ, Hu XS, Liu J and Wang TH: Transplantation of bone
marrow- derived mesenchymal stem cells (BMSCs) improves brain
ischemia-induced pulmonary injury in rats associated to TNF-α
expression. Behav Brain Funct. 12:92016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ryerson CJ, Cayou C, Topp F, Hilling L,
Camp PG, Wilcox PG, Khalil N, Collard HR and Garvey C: Pulmonary
rehabilitation improves long-term outcomes in interstitial lung
disease: A prospective cohort study. Respir Med. 108:203–210. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Trudzinski FC, Kaestner F, Schäfers HJ,
Fähndrich S, Seiler F, Böhmer P, Linn O, Kaiser R, Haake H, Langer
F, et al: Outcome of patients with interstitial lung disease
treated with extracorporeal membrane oxygenation for acute
respiratory failure. Am J Respir Crit Care Med. 193:527–533. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Volkmann ER and Tashkin DP: Treatment of
systemic sclerosis-related interstitial lung disease: A review of
existing and emerging therapies. Ann Am Thorac Soc. 13:2045–2056.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hutchinson JP, Fogarty AW, McKeever TM and
Hubbard RB: In-hospital mortality after surgical lung biopsy for
interstitial lung disease in the United States. 2000 to 2011. Am J
Respir Crit Care Med. 193:1161–1167. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen H, Zhong JM, Yi ZS, Zha J, Chen Y and
Cai LY: Immunological mechanism of prednisone in the treatment of
infantile spasm. Zhongguo Dang Dai Er Ke Za Zhi. 19:1044–1050.
2017.(In Chinese). PubMed/NCBI
|
|
18
|
Witt LJ, Demchuk C, Curran JJ and Strek
ME: Benefit of adjunctive tacrolimus in connective tissue
disease-interstitial lung disease. Pulm Pharmacol Ther. 36:46–52.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kundu S, Paul S, Hariprasath K, Agarwal R,
Ghosh S and Biswas D: Effect of sequential intravenous pulse
cyclophosphamide-azathioprine in systemic sclerosis-interstitial
lung disease: An open-label study. Indian J Chest Dis Allied Sci.
58:7–10. 2016.PubMed/NCBI
|
|
20
|
Yunyun F, Yu C, Panpan Z, Hua C, Di W,
Lidan Z, Linyi P, Li W, Qingjun W, Xuan Z, et al: Efficacy of
cyclophosphamide treatment for immunoglobulin G4-related disease
with addition of glucocorticoids. Sci Rep. 7:61952017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Daillère R, Vétizou M, Waldschmitt N,
Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C,
Lepage P, Roberti MP, et al: Enterococcus hirae and
Barnesiella intestinihominis facilitate
cyclophosphamide-induced therapeutic immunomodulatory effects.
Immunity. 45:931–943. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mok CC: Con: Cyclophosphamide for the
treatment of lupus nephritis. Nephrol Dial Transplant.
31:1053–1057. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gerards MC, Venema GE, Patberg KW, Kross
M, Potter van Loon BJ, Hageman IMG, Snijders D, Brandjes DPM,
Hoekstra JBL, Vriesendorp TM, et al: Dapagliflozin for
prednisone-induced hyperglycaemia in acute exacerbation of chronic
obstructive pulmonary disease. Diabetes Obes Metab. 20:1306–1310.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tashkin DP, Roth MD, Clements PJ, Furst
DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja
S, et al Sclerodema Lung Study II Investigators, : Mycophenolate
mofetil versus oral cyclophosphamide in scleroderma-related
interstitial lung disease (SLS II): A randomised controlled,
double-blind, parallel group trial. Lancet Respir Med. 4:708–719.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mulvenna P, Nankivell M, Barton R,
Faivre-Finn C, Wilson P, McColl E, Moore B, Brisbane I, Ardron D,
Holt T, et al: Dexamethasone and supportive care with or without
whole brain radiotherapy in treating patients with non-small cell
lung cancer with brain metastases unsuitable for resection or
stereotactic radiotherapy (QUARTZ): Results from a phase 3,
non-inferiority, randomised trial. Lancet. 388:2004–2014. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang AX, Lu LW, Liu WJ and Huang M:
Plasma inflammatory cytokine IL-4, IL-8, IL-10, and TNF-α levels
correlate with pulmonary function in patients with asthma - chronic
obstructive pulmonary disease (COPD) overlap syndrome. Med Sci
Monit. 22:2800–2808. 2016. View Article : Google Scholar : PubMed/NCBI
|
